Shamiram Feinglass, MD, MPH

Dr. Feinglass is the Chief Medical Officer for Danaher DxLS and Beckman Coulter. Driving inclusion and diversity in every environment in which she works or leads, Dr. Feinglass leads Global Medical Affairs, Reimbursement, & Health Policy for Life Sciences and Diagnostics and is responsible for leading the global pandemic response plan across the company, inclusive of all 70,000 associates.

Often working with global leaders and regulators, Dr. Feinglass formerly led Global Medical and Regulatory Affairs at Zimmer, Inc., has served as a Medical Officer at the Centers for Medicare and Medicaid Services, in the Coverage and Analysis Group, and as a Commander with the U.S. Public Health Service. She has also been clinical faculty at several health sciences universities and her work has been widely published.

A graduate of Smith College, Dr. Feinglass earned her Doctor of Medicine and Master of Public Health from the Emory Schools of Medicine and Public Health. She completed an Internal Medicine Residency at Oregon Health Sciences University, a Preventive Medicine Residency at Emory School of Medicine, and the Robert Wood Johnson Clinical Scholars Program at the University of Washington. A sought-after speaker and expert in international medical device and diagnostics policy, Dr. Feinglass has served on a variety of panels for the FDA, FasterCures, The Brookings Institute, Pew Charitable Trusts, Oxford University, and international registry groups.

A mother of two, she is currently a BMX state champion and was a member of the USA BMX World Championship Team. Dr. Feinglass was an Aspen Health Innovators Fellow and is a member of the Aspen Global Leadership Network.